Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

Detalles Bibliográficos
Autores principales: Mainz, Jochen G., Zagoya, Carlos, Polte, Louise, Naehrlich, Lutz, Sasse, Lenny, Eickmeier, Olaf, Smaczny, Christina, Barucha, Anton, Bechinger, Lilith, Duckstein, Franziska, Kurzidim, Ludwik, Eschenhagen, Patience, Caley, Laura, Peckham, Daniel, Schwarz, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189544/
https://www.ncbi.nlm.nih.gov/pubmed/37205908
http://dx.doi.org/10.3389/fphar.2023.1207356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189544/
https://www.ncbi.nlm.nih.gov/pubmed/37205908
http://dx.doi.org/10.3389/fphar.2023.1207356

Ejemplares similares